Contact Congress about S. 2770: Share the Savings with Seniors Act

Starting in 2027, some Medicare Part D members would pay based on a lower after-discount drug price for certain chronic-condition medicines. The bill also limits what some low-income seniors can be charged for those same drugs.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Share the Savings with Seniors Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.

Latest action on S. 2770: Read twice and referred to the Committee on Finance.

Who this affects: This bill mainly affects Medicare Part D members who take regular medicine for long-term health problems and pay a share of the drug’s price. It also affects low-income seniors who get Extra Help, because their copays for certain chronic drugs could be limited. Drug plans, pharmacies, pharmacy benefit managers that run drug benefits, and federal health officials would also have to adjust how these prices and charges are set.

Why this matters: Many seniors with chronic illnesses take expensive drugs every month, and some pay a percentage of a price that can be higher than what the plan really pays after discounts. This bill tries to move some of that discount value to the patient at the pharmacy counter. It could lower out-of-pocket costs for some people, especially those using coinsurance. But the bill does not say whether plans would respond by changing premiums or redesigning benefits.

Key provisions in S. 2770

• These rules would start with Medicare Part D plans in 2027.
• Before a person meets the yearly deductible, the plan could not charge more than the drug’s net price for a covered chronic-care drug. Net price means the price after manufacturer rebates and discounts.
• After the deductible and before the out-of-pocket spending limit, coinsurance for these chronic drugs would have to use the net price. It could not use a higher list price or benchmark price when coinsurance is the plan’s method.
• Plans can still use a flat copay in some cases. If the charge is a set dollar amount and not tied to a drug price, this net-price coinsurance rule does not apply.
• The bill covers only certain drugs defined as chronic-care drugs. It uses specific United States Pharmacopeia, or USP, Medicare drug classes, including some diabetes, breathing, blood-thinner, and heart medicines.

How Modern Action helps you take action on S. 2770

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 2770

What is S. 2770?

Starting in 2027, some Medicare Part D members would pay based on a lower after-discount drug price for certain chronic-condition medicines. The bill also limits what some low-income seniors can be charged for those same drugs.

How do I support or oppose S. 2770?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about S. 2770?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain S. 2770 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.